Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells

Cancer Gene Therapy

Volumn 6, Issue 5, 1999, Pages 428-436

  Cascallo M ^a   Mercade E ^a   Capella G ^b   Lluis F ^b   Fillat, C ^c   Gomez Foix A M ^a   Mazo, A ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Institut de Recerca Oncologica   (Spain)

^d Dept of Biochem and Molec Biology ^*  (Spain)

Author keywords

Adenovirus; Apoptosis; Cell cycle; p16; p53; Pancreatic cancer

Indexed keywords

ETOPOSIDE; PROTEIN P53;

ADENOCARCINOMA; ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; DRUG EFFECT; GENE VECTOR; GENETICS; HUMAN; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL CYCLE; ETOPOSIDE; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033190986     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700070     Document Type: Article

References (41)

1. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J. Clin. 1995;45:8-30.
2. Lionetto R, Pugliese V, Bruzzi P, Rosso R. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer. 1995;31A:882-887.
3. Roth JA, Cristiano RJ. Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst. 1997;89:21-39.
4. Bishop JM. Molecular themes in oncogenesis. Cell. 1991; 64:235-248.
5. King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem. 1995;8:175-185.
6. Culver KW, Blaese RM. Gene therapy for cancer. Trends Genet. 1994;10:174-178.
7. Hollstein M, Sidranski D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49-53.
8. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst. 1996;88:1442-1455.
9. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev. 1996;10:1054-1072.
10. Haffner R, Oren M. Biochemical properties and biological effects of p53. Curr Opin Genet Dev. 1995;5:84-90.
11. Nielsen LL, Maneval DC. p53 tumor suppressor gene therapy for cancer. Cancer Gene Ther. 1998;5:52-63.
12. El-Deiry WS, Tokino K, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75:817-825.
13. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701-704.
14. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med. 1997;3:313-318.
15. INK4a. Cell. 1997;88: 593-602.
16. 2/M by p53. Oncogene. 1995;10:109-115.
17. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Nail Acad Sci USA. 1995;92:8493-8497.
18. 2 exit of the cell cycle: role in the DNA-damage induced apoptosis. Oncogene. 1995;10:2263-2270.
19. 2 to M transition: implications for gene therapy. Cancer Res. 1997;57:818-823.
20. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389: 300-305.
21. Becker TC, Noel RJ, Coats WS, et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 1994;5:161-189.
22. Zhang WW, Fang XF, Mazur W, French BA, Georges RN, Roth JA. High efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1994;1:4-15.
23. Zabner J, Petersen DM, Puga AP, et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet. 1994;6:75-83.
24. Wills KN, Maneval DC, Menzel P, et al. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther. 1994;5:1079-1088.
25. Wang J, Bucana CD, Roth JA, Zhang WW. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53. Cancer Gene Ther. 1995;2:9-17.
26. Sobol R, Scanlon KJ. Cancer gene therapy, clinical trials. Cancer Gene Ther. 1995;2:5-6.
27. 1 arrest and induces apoptosis in human cancer cells. Oncogene. 1997;5:1903-1909.
28. Reyes G, Villanueva A, García C, et al. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res. 1996;56:5713-5719.
29. Darzynkiewicz Z, Li X, Gong J, Hara S, Traganos. Analysis of cell death by flow cytometry. In: Rickwood D, Hames BD, eds. Cell Growth and Apoptosis: A Practical Approach, 1st ed. NY: Oxford University Press, 1995: 143-167.
30. Favrot M, Coll JL, Louis N, Negoescu A. Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Ther. 1998;5: 728-739.
31. Kimura M, Tagawa M, Takenaga K, et al. Inability to induce the alteration of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene. Anticancer Res. 1997;17:879-884.
32. Lang D, Miknyoczki SJ, Huang L, Ruggeri BA. Stable reintroduction of wild-type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells Oncogene. 1998;16:1593-1602.
33. Gómez-Manzano C, Fueyo J, Kyritsis P, et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 1996;56:694-699.
34. Liu TJ, El-Naggar K, McDonnell TJ, et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 1995;55:3117-3122.
35. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996;10:1945-1952.
36. Gómez-Manzano C, Fueyo J, Kyritsis AP, et al. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst. 1997;89: 1036-1044.
37. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
38. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
39. Lukas J, Parry D, Aagaard L, et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 1995;375:503-506.
40. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74:957-967.
41. Fujiwara T, Grimm EA, Mukhoadhyay T, Zhang WW, Owe-Schaub B, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 1994;54: 2287-2291.